Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | ELANE | P08246 | 1/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.51 |
| ▸ | CDC25B | P30305 | 2/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29370485 | 1.00 | LMNA (0.54) | LMNACYP1A2CYP3A4MAOAELANE | |
| SCHEMBL285618 | 1.00 | LMNA (0.54) | LMNACYP1A2CYP3A4MAOAELANE | |
| Methane SCHEMBL2132580 | 0.98 | ELANE (0.53) | LMNACYP1A2CYP3A4MAOAELANE | |
| Hydrochloric Acid SCHEMBL7319745 | 0.98 | ELANE (0.53) | LMNACYP1A2CYP3A4MAOAELANE | |
| SCHEMBL29465556 | 0.92 | LMNA (0.62) | LMNACYP1A2CYP3A4MAOAELANE | |
| SCHEMBL133366 | 0.92 | LMNA (0.62) | LMNACYP1A2CYP3A4MAOAELANE | |
| Methane SCHEMBL15286491 | 0.91 | LMNA (0.61) | LMNACYP1A2CYP3A4MAOAELANE | |
| Hydrochloric Acid SCHEMBL642777 | 0.91 | LMNA (0.61) | LMNACYP1A2CYP3A4MAOAELANE | |
| Ethylamine SCHEMBL27494386 | 0.88 | LMNA (0.57) | LMNACYP1A2CYP3A4MAOAELANE | |
| 3-Aminobenzoic Acid SCHEMBL8220213 | 0.86 | LMNA (0.56) | LMNACYP1A2CYP3A4MAOAELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074420-A | Evaluation method of bile acid in relieving intestinal inflammation of east star spots | — | 2026-05-26 | — | — | CN | claimed |
| CN-121674260-B | Microorganism composite flora for treating aquaculture tail water and application thereof | 南京万瑞环境科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4460178-A1 | METHOD TO DETACH ECTOPARASITES FROM FISH | Intervet International B.V. (NL) | 2024-11-13 | — | — | EP | claimed |
| CN-118901628-A | Construction method of zebra fish bacterial inflammation model | 江苏国生质检科技有限公司 | 2024-11-08 | — | — | CN | claimed |
| US-20240207454-A1 | NEURO-BEHAVIORAL ASSAY FOR PHYSIOLOGICAL EVALUATION OF WATER-SOLUBLE ANESTHETICS | NORTHEASTERN UNIVERSITY | 2024-06-27 | — | — | US | claimed |
| WO-2023131615-A1 | METHOD TO DETACH ECTOPARASITES FROM FISH | INTERVET INTERNATIONAL B.V. (NL) | 2023-07-13 | — | — | WO | claimed |
| US-20160287528-A1 | METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE | CHEMAPHOR INC. (CA) | 2016-10-06 | — | — | US | claimed |
| US-20130156816-A1 | METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE | CHEMAPHOR INC. (CA) | 2013-06-20 | — | — | US | claimed |
| EP-2536293-A1 | METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE | Chemaphor Inc. (CA) | 2012-12-26 | — | — | EP | claimed |
| WO-2011103464-A1 | METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE | CHEMAPHOR INC. (CA) | 2011-08-25 | — | — | WO | claimed |
| CN-122074420-A | Evaluation method of bile acid in relieving intestinal inflammation of east star spots | — | 2026-05-26 | — | — | CN | disclosed |
| CN-121674260-B | Microorganism composite flora for treating aquaculture tail water and application thereof | 南京万瑞环境科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-121674260-B | Microorganism composite flora for treating aquaculture tail water and application thereof | 南京万瑞环境科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2026102322-A1 | METHODS AND SYSTEMS FOR MODIFYING MOTILITY OF ENGINEERED MULTICELLULAR ORGANISMS | TRUSTEES OF TUFTS COLLEGE (US) | 2026-05-15 | — | — | WO | disclosed |
| CN-122006607-A | Natural plant compound microcapsule for aquatic product transportation and keep-alive and application thereof | 泰山学院 | 2026-05-12 | — | — | CN | disclosed |
| US-5434295-A | Central nervous system | YISSUM RESEARCH DEVELOPMENT COMPANY (IL) | 1995-07-18 | — | — | US | disclosed |
| EP-0642504-A1 | (3S,4S)-DELTA-6-TETRAHYDROCANNABINOL-7-OIC ACIDS AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1995-03-15 | — | — | EP | disclosed |
| EP-0642504-A4 | (3S,4S)-DELTA-6-TETRAHYDROCANNABINOL-7-OIC ACIDS AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | YISSUM RES DEV CO (IL) | 1994-08-22 | — | — | EP | disclosed |
| WO-1993005031-A1 | (3S,4S)-DELTA-6-TETRAHYDROCANNABINOL-7-OIC ACIDS AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY IN JERUSALEM (IL) | 1993-03-18 | — | — | WO | disclosed |
| EP-0501445-A1 | Pharmaceutical composition comprising interleukin-2 | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1992-09-02 | — | — | EP | disclosed |